Feb 5 |
Genprex Announces First Patient Dosed in Phase 2a Expansion of Acclaim-1 Clinical Study of Reqorsa® Therapy in Combination with Tagrisso® to Treat Non-Small Cell Lung Cancer
|
Jan 31 |
Why AMD Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
|
Jan 31 |
Crude Oil Down 2%; Alphabet Shares Fall After Q4 Results
|
Jan 31 |
Genprex to effect 1-for-40 reverse stock split to regain Nasdaq compliance
|
Jan 31 |
Genprex Announces 1-for-40 Reverse Stock Split Effective February 2, 2024
|
Jan 5 |
Genprex Provides Business Update and Outlook for 2024
|
Nov 23 |
Genprex Granted Orphan Drug Designation in Small Cell Lung Cancer
|
Nov 3 |
Genprex to Present at BIO-Europe 2023
|
Nov 1 |
Genprex to Present at BIO-Europe 2023 Conference
|